Glucagon-like peptide-1 mRNA

Glucagon-like peptide-1 mRNA has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 24, 2026: “Stomach dosing increased nanoparticle delivery in rodents”.

Intervention

1 paper studies it1 findingUpdated Oct 13, 2026

1 new paper in 30 daysSee all 1

1 lab in 1 country

Funders: Division of Electrical, Communications and Cyber Systems and others

Animals1

What did studies of Glucagon-like peptide-1 mRNA find?

Studies of Glucagon-like peptide-1 mRNA measured 1 outcome; the most studied are blood glucose regulation (1 study).

Blood glucose regulation

upin mice1

1 study

Glucagon-like peptide-1 mRNA improves blood glucose regulation in mice.
“Gastric dosing of glucagon-like peptide-1 mRNA also improved blood glucose regulation in mice compared with phosphate-buffered saline controls.”
Animalsgastric dosing compared with phosphate-buffered saline controls
Stomach dosing increased nanoparticle delivery in rodents
ACS nanoOct 13, 2026

Latest

1 paper in 12 months

ACS NanoOct 24

Stomach dosing increased nanoparticle delivery in rodents

Delivery to the pancreas was an order of magnitude greater after dosing into stomach tissue than after intravenous administration.Delivery to the pancreas was an order of magnitude greater after dosing into stomach tissue than after intravenous administration.

Mouse studyInterventions

Paper

Glucagon-like peptide-1 mRNA

What did studies of Glucagon-like peptide-1 mRNA find?

Latest

Stomach dosing increased nanoparticle delivery in rodents

Related